Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_assertion type Assertion NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_head.
- NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_assertion description "[Low EMX2 mRNA expression is significantly associated with decreased OS and RFS in patients with lung adenocarcinoma, particularly with stage I disease and BAC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_provenance.
- NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_assertion evidence source_evidence_literature NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_provenance.
- NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_assertion SIO_000772 21726823 NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_provenance.
- NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_assertion wasDerivedFrom befree-20140225 NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_provenance.
- NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_assertion wasGeneratedBy ECO_0000203 NP800941.RAAXa9LsoIDzRim6-bYjhg6MwXRwxhcA4qRoWkzQCWuZA130_provenance.